Joachim Schuster

ORCID: 0000-0002-4207-1312
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Amyotrophic Lateral Sclerosis Research
  • Neurogenetic and Muscular Disorders Research
  • Parkinson's Disease Mechanisms and Treatments
  • Protein purification and stability
  • Monoclonal and Polyclonal Antibodies Research
  • Labor Movements and Unions
  • biodegradable polymer synthesis and properties
  • Microfluidic and Bio-sensing Technologies
  • Neurological diseases and metabolism
  • Genomics, phytochemicals, and oxidative stress
  • Social Policy and Reform Studies
  • Breast Cancer Treatment Studies
  • Cancer-related gene regulation
  • Transgenic Plants and Applications
  • Breast Lesions and Carcinomas
  • European Socioeconomic and Political Studies
  • Photosynthetic Processes and Mechanisms
  • Polyomavirus and related diseases
  • Congenital Anomalies and Fetal Surgery
  • Cholinesterase and Neurodegenerative Diseases
  • Viral Infectious Diseases and Gene Expression in Insects
  • Nitrogen and Sulfur Effects on Brassica
  • Dental materials and restorations
  • Drug Solubulity and Delivery Systems
  • Hereditary Neurological Disorders

Universität Ulm
2007-2025

German Center for Neurodegenerative Diseases
2022-2024

Lonza (Switzerland)
2020-2024

University Hospital Ulm
2022-2024

SMART Reading
2024

Marienhospital Stuttgart
2023

Stuttgart Observatory
2023

Klinikum Ludwigsburg
2023

University of Basel
2020-2021

LMU Klinikum
2016

Heterozygous missense mutations in the N-terminal motor or coiled-coil domains of kinesin family member 5A (KIF5A) gene cause monogenic spastic paraplegia (HSP10) and Charcot-Marie-Tooth disease type 2 (CMT2). Moreover, heterozygous de novo frame-shift C-terminal domain KIF5A are associated with neonatal intractable myoclonus, a neurodevelopmental syndrome. These findings, together observation that many genes amyotrophic lateral sclerosis disrupt cytoskeletal function intracellular...

10.1093/brain/awx370 article EN cc-by-nc Brain 2017-12-22

Objective Weight loss has been identified as a negative prognostic factor in amyotrophic lateral sclerosis, but there is no evidence regarding whether high‐caloric diet increases survival. Therefore, we sought to evaluate the efficacy of fatty (HCFD) for increasing Methods A 1:1 randomized, placebo‐controlled, parallel‐group, double‐blinded trial (LIPCAL‐ALS study) was conducted between February 2015 and September 2018. Patients were followed up at 3, 6, 9, 12, 15, 18 months after...

10.1002/ana.25661 article EN Annals of Neurology 2019-12-18

Abstract As part of our analysis branched-chain amino acid metabolism in plants, we analyzed the function Arabidopsis thaliana BRANCHED-CHAIN AMINOTRANSFERASE4 (BCAT4). Recombinant BCAT4 showed high efficiency with Met and its derivatives corresponding 2-oxo acids, suggesting participation chain elongation pathway Met-derived glucosinolate biosynthesis. This was substantiated by vivo two T-DNA knockout mutants, which aliphatic accumulation is reduced ∼50%. The increase free...

10.1105/tpc.105.039339 article EN The Plant Cell 2006-10-01

Objectives Recent advances in amyotrophic lateral sclerosis (ALS) genetics have revealed that mutations any of more than 25 genes can cause ALS, mostly as an autosomal-dominant Mendelian trait. Detailed knowledge about the genetic architecture ALS a specific population will be important for counselling but also genotype-specific therapeutic interventions. Methods Here we combined fragment length analysis, repeat-primed PCR, Southern blotting, Sanger sequencing and whole exome to obtain...

10.1136/jnnp-2017-317611 article EN Journal of Neurology Neurosurgery & Psychiatry 2018-04-12

Valine, leucine and isoleucine contain short branched carbohydrate residues responsible for their classification as branched‐chain amino acids (BCAA). Among the proteinogenic acids, BCAA show highest hydrophobicity are accordingly major constituents of transmembrane regions membrane proteins. cannot be synthesized by humans thus belong to essential acids. In contrast, plants able synthesize these de novo an important source compounds in human diet. However, only plants, probably also valine...

10.1111/j.1399-3054.2006.00800.x article EN Physiologia Plantarum 2006-11-07

Abstract Branched-chain amino acid transaminases (BCATs) play a crucial role in the metabolism of leucine, isoleucine, and valine. They catalyze last step synthesis and/or initial degradation this class acids. In Arabidopsis, seven putative BCAT genes are identified by their similarity to counterparts from other organisms. We have now cloned respective cDNA sequences six these genes. The deduced show between 47.5% 84.1% identity each about 30% homologous enzymes yeast (Saccharomyces...

10.1104/pp.001602 article EN PLANT PHYSIOLOGY 2002-06-01

Abstract In Arabidopsis thaliana, transamination steps in the leucine biosynthetic and catabolic pathways methionine (Met) chain elongation cycle of aliphatic glucosinolate formation are catalyzed by branched-chain aminotransferases (BCATs) that encoded a small gene family six members. One member this family, plastid-located BCAT3, was shown to participate both amino acid metabolism. vitro activity tests with recombinant protein identified highest activities 2-oxo acids leucine, isoleucine,...

10.1104/pp.107.111609 article EN cc-by PLANT PHYSIOLOGY 2007-12-27
Albert C. Ludolph Joachim Schuster Johannes Dorst Luc Dupuis Jens Dreyhaupt and 95 more Jochen H. Weishaupt Jan Kassubek Ulrike Weiland Susanne Petri Thomas Meyer Julian Großkreutz Berthold Schrank Matthias Boentert Alexander Emmer Andreas Hermann Daniel Zeller Johannes Prudlo Andrea Sylvia Winkler Torsten Grehl Michael T. Heneka Siw Johannesen Bettina Göricke Andreas Funke Dagmar Kettemann Thomas Meyer Thomas Meyer Torsten Grehl Kai Gruhn Peter Schwenkreis Philipp Stude Michael T. Heneka Delia Kurzwelly Andreas Hermann Alexander Storch Nicole Richter Tobias Frank Bettina Göricke Katharina Hein Alexander Emmer Frank Hanisch Dagmar Hanke Torsten Kraya Andreas Posa Martina Romanakova Susanne Schilling Susanne Abdulla Sebastian Böselt Dagmar Hanke Claas Janssen Imken Lange Xenia Kobeleva Sonja Körner Katja Kollewe Alma Osmanovic Susanne Petri Nicole Scharn Klaus Jan Rath Christiane Dahms Julian Großkreutz A. Gunkel Bianka Heiling Thomas Ringer Uta Smesny Sarah Baumeister Achim Berthele Sarah Bublitz Andrea Sylvia Winkler E Akova-Öztürk Matthias Boentert Bianca Stubbe-Dräger Alexandra Rahmann Charlotte Young Peter C. Young Dobri Baldaranov Ulrich Bogdahn Siw Johannesen Andrei Khomenko Wilhelm Schulte‐Mattler Christina Stadler Susanne Husung Johannes Prudlo Simone Tesar Nigar Dargah-Zaden Christina Last Eva Langer Albert C. Ludolph Jochen H. Weishaupt Ulrike Weiland Ann-Sophie Lauenstein Eckard Lensch Carolyn Mc Farlane Heike Fischer-Brasse Klara Orbán Bertold Schrank Sonja Schürger Stephan Klebe Peter Kraft Thomas Musacchio Carola Seiler Daniel Zeller

10.1016/s1474-4422(18)30176-5 article EN The Lancet Neurology 2018-06-19

Therapy of motoneuron diseases entered a new phase with the use intrathecal antisense oligonucleotide therapies treating patients specific gene mutations predominantly in context familial amyotrophic lateral sclerosis. With majority cases being sporadic, we conducted cohort study to describe mutational landscape sporadic We analysed genetic variants sclerosis-associated genes assess and potentially increase number eligible for gene-specific therapies. screened 2340 sclerosis from German...

10.1093/braincomms/fcad152 article EN cc-by Brain Communications 2023-01-01

An expansion of the GGGGCC hexanucleotide in non-coding region C9orf72 represents most common cause familial amyotrophic lateral sclerosis. The objective was to describe and analyse clinical genetic features sclerosis patients with mutations a large population. Between November 2011 December 2020, characteristics n = 248 carrying were collected from scientific network German motoneuron disease centres. Clinical parameters included age onset, diagnostic delay, family history,...

10.1093/braincomms/fcad087 article EN cc-by Brain Communications 2023-03-02

Objective Neurofilament light chains (NfL) and phosphorylated neurofilament heavy (pNfH), established as diagnostic prognostic biomarkers in hospital‐based amyotrophic lateral sclerosis (ALS) cohorts, are now surrogate markers clinical trials. This study extends their evaluation to a population level, with the aim of advancing full establishment assessing transferability biomarker findings from controlled cohorts real‐world ALS populations. Methods We measured serum NfL pNfH levels all...

10.1002/ana.27054 article EN cc-by-nc Annals of Neurology 2024-08-23

Plasma exchange (PE) constitutes the standard therapy for steroid-refractory relapse in multiple sclerosis and clinically isolated syndrome. Immunoadsorption (IA) is an alternative method of apheresis which selectively removes immunoglobulines (Ig) while preserving other plasma proteins. Although IA regarded as a well-tolerated, low-risk procedure, high-level evidence its efficacy lacking. Therefore, we sought to investigate whether superior PE patients with acute or syndrome who had...

10.1016/j.eclinm.2019.10.017 article EN cc-by-nc-nd EClinicalMedicine 2019-11-01

Abstract Background Interventional trials in amyotrophic lateral sclerosis (ALS) suffer from the heterogeneity of disease as it considerably reduces statistical power. We asked if blood neurofilament light chains (NfL) could be used to anticipate progression and increase trial Methods In 125 patients with ALS three independent prospective studies—one observational study two interventional trials—we developed externally validated a multivariate linear model for predicting progression,...

10.1186/s40035-021-00257-y article EN cc-by Translational Neurodegeneration 2021-08-26

Abstract Background The ALS Functional Rating Scale in its revised version (ALSFRS-R) is a disease-specific severity score that reflects motor impairment and functional deterioration people with amyotrophic lateral sclerosis (ALS). It has been widely applied both clinical practice research. However, Germany, several variants of the scale, each differing slightly from others, have developed over time are currently circulation. This lack uniformity potentially hampers data interpretation may...

10.1186/s42466-022-00224-6 article EN cc-by Neurological Research and Practice 2022-12-15

Objective There is growing evidence that the course of amyotrophic lateral sclerosis (ALS) may be influenced beneficially by applying high-caloric food supplements (HCSs). However, it unknown which composition nutrients offers optimal tolerability and weight gain. Methods We conducted a randomised controlled study (Safety Tolerability Ultra-high-caloric Food Supplements in Amyotrophic Lateral Sclerosis (ALS); TOLCAL-ALS study) 64 patients with possible, probable or definite ALS according to...

10.1136/jnnp-2021-328331 article EN Journal of Neurology Neurosurgery & Psychiatry 2022-01-12

Laboratory capacities are often limited by time-consuming manual repetitive procedures rather than analysis time itself. While modern instruments typically equipped with an autosampler, sample preparation follows including many labor-intensive, monotonous tasks. Particularly, for a high number of samples, well plates, and low microliter pipetting, is error-prone requiring repeated experiments. Sampling can account greater analytical variability instrument analysis. Repetitive tasks such as...

10.1016/j.slast.2024.100128 article EN cc-by-nc-nd SLAS TECHNOLOGY 2024-03-18

Abstract Tofersen is the first effective and approved therapy for familial ALS caused by pathogenic variants in SOD1 gene. Following treatment with tofersen, neurofilaments patients CSF serum display a faster response than clinical parameters, underlining their importance as biomarker trials. This evidence led us to hypothesize that this novel might represent an opportunity identify additional therapy-responsive biomarkers ALS. We chose commercial NUcleic acid Linked Immuno-Sandwich Assay...

10.1101/2024.04.22.24306165 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2024-04-24

Patients with amyotrophic lateral sclerosis (ALS) suffer from dysphagia that increases the risk for aspiration, pneumonia and weight loss. Pharyngeal electrical stimulation (PES) is a therapeutic technique applies electric stimuli to patient's pharynx in order improve swallowing based on principle of cortical plasticity reorganization. Previous studies have demonstrated positive effects patients various neurological diseases.This study was initiated investigate effect PES function ALS.In...

10.1177/17562864211068394 article EN cc-by-nc Therapeutic Advances in Neurological Disorders 2022-01-01
Coming Soon ...